Intra-Cellular Therapies Inc (NASDAQ:ITCI)

44.61
Delayed Data
As of Sep 27
 +1.91 / +4.47%
Today’s Change
34.43
Today|||52-Week Range
66.00
-14.77%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Riggs Rory B
Director
Sale3/17/2022114,912$60.41$6.9M-26.17%
Halstead Michael
General Counsel & Executive Vice President
Sale12/21/2021104,775$47.84$5.0M-7.51%
Neumann Mark /intr/
EVP & Chief Commercial Officer
Sale4/08/202253,987$64.42$3.5M-30.99%
Riggs Rory B
Director
Sale3/16/202243,848$59.53$2.6M-25.36%
Halstead Michael
General Counsel & Executive Vice President
Sale12/21/202136,434$46.87$1.7M-7.51%
Van Nostrand Robert L
Director
Sale8/11/202228,500$57.15$1.6M-21.82%
Mates Sharon
Chairman, President & Chief Executive Officer
Sale10/15/202140,392$40.00$1.6M+13.44%
Riggs Rory B
Director
Sale3/17/202226,587$59.99$1.6M-26.17%
Halstead Michael
General Counsel & Executive Vice President
Buy12/21/202188,146$17.57$1.5M-7.51%
Hineline Lawrence J
Sale9/21/202233,303$45.39$1.5M+0.75%
Page of 11